Literature DB >> 19876665

Improving outpatient treatment in schizophrenia: effects of computerized guideline implementation--results of a multicenter-study within the German research network on schizophrenia.

B Janssen1, S Ludwig, H Eustermann, R Menke, M Haerter, M Berger, G Adam, U Seemann, W Kissling, W Gaebel.   

Abstract

Schizophrenia clinical practice guidelines are developed to provide expert- and evidence-based advice to practicing psychiatrists in order to improve the management of this disorder. However, the application of these guidelines in everyday health care can still be described as nonsatisfying. Within the project "Guideline-supported quality management in outpatient treatment", we investigated whether guideline adherence and quality of outcome can be improved by implementing a computer-based, guideline-oriented decision-support system. Therefore, a disease-specific decision-support system was developed interactively presenting guidelines to support the physicians decision-making process during the treatment of schizophrenia patients. We evaluated the system in a control group design: An experimental group consisting of 15 psychiatrists in private practice used the decision-support system, thus documenting the treatment of schizophrenic patients. Guideline-based algorithms were interactively and case specifically displayed on the PC-screen as soon as predefined triggers were met. A first control group in Munich provided treatment-as-usual, documenting the treatment via paper-pencil. Two further physician groups served as additional comparison groups: one also documented electronically using the decision-support system, however without receiving electronic guideline support, the second group carried out traditional quality circles while also using the paper-pencil approach. As a result of the intervention, we observed a strong initial but time-limited improvement with respect to the core aspects of outpatient treatment in schizophrenia in the experimental group. The findings suggest that decision-support systems, despite their limitations, can be used to enhance treatment outcome in schizophrenia outpatient care.

Entities:  

Mesh:

Year:  2009        PMID: 19876665     DOI: 10.1007/s00406-009-0016-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  21 in total

1.  PQM--Psychiatry Quality Measurement.

Authors:  A F Joubert
Journal:  Int Clin Psychopharmacol       Date:  2001-04       Impact factor: 1.659

2.  Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project.

Authors: 
Journal:  Qual Saf Health Care       Date:  2003-02

3.  [Fragmentation of the doctor-patient relationship as a result of standardisation and economisation].

Authors:  Hans F Kienzle
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2004-05

4.  Perceived effectiveness of diagnostic and therapeutic guidelines in primary care quality circles.

Authors:  B D Tausch; M C Härter
Journal:  Int J Qual Health Care       Date:  2001-06       Impact factor: 2.038

5.  Schizophrenia practice guidelines: international survey and comparison.

Authors:  Wolfgang Gaebel; Stefan Weinmann; Norman Sartorius; Wolfgang Rutz; John S McIntyre
Journal:  Br J Psychiatry       Date:  2005-09       Impact factor: 9.319

6.  The concurrent validity of the Global Assessment of Functioning (GAF).

Authors:  Mike Startup; Mike C Jackson; Sue Bendix
Journal:  Br J Clin Psychol       Date:  2002-11

7.  The Texas medication algorithm project: clinical results for schizophrenia.

Authors:  Alexander L Miller; M Lynn Crismon; A John Rush; John Chiles; T Michael Kashner; Marcia Toprac; Thomas Carmody; Melanie Biggs; Kathy Shores-Wilson; Judith Chiles; Brad Witte; Christine Bow-Thomas; Dawn I Velligan; Madhukar Trivedi; Trisha Suppes; Steven Shon
Journal:  Schizophr Bull       Date:  2004       Impact factor: 9.306

8.  Translating research into practice: the Schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations.

Authors:  A F Lehman; D M Steinwachs
Journal:  Schizophr Bull       Date:  1998       Impact factor: 9.306

9.  [A good clinical guideline is an orientational tool, not a checklist].

Authors:  Jörg-Dietrich Hoppe
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2004-05

10.  Medical decision making in antipsychotic drug choice for schizophrenia.

Authors:  Johannes Hamann; Bernadette Langer; Stefan Leucht; Raymonde Busch; Werner Kissling
Journal:  Am J Psychiatry       Date:  2004-07       Impact factor: 18.112

View more
  11 in total

Review 1.  [Treatment pathways in the care of patients with schizophrenia and depression].

Authors:  H J Salize; E Voß; A Werner; P Falkai; I Hauth
Journal:  Nervenarzt       Date:  2015-11       Impact factor: 1.214

Review 2.  [Neurobiology of behavioral addictions].

Authors:  F Kiefer; M Fauth-Bühler; A Heinz; K Mann
Journal:  Nervenarzt       Date:  2013-05       Impact factor: 1.214

3.  Clinical practice guidelines in the AANS/CNS Section on Tumors: past, present and future directions.

Authors:  Mark E Linskey; Jeffrey J Olson; Laura S Mitchell; Steven N Kalkanis
Journal:  J Neurooncol       Date:  2014-08-01       Impact factor: 4.130

Review 4.  Computer-Based Clinical Decision Support Systems and Patient-Reported Outcomes: A Systematic Review.

Authors:  David Blum; Sunil X Raj; Rolf Oberholzer; Ingrid I Riphagen; Florian Strasser; Stein Kaasa
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

5.  A further evaluation of decision-making under risk and under ambiguity in schizophrenia.

Authors:  Guillaume Fond; Sophie Bayard; Delphine Capdevielle; Jonathan Del-Monte; Nawale Mimoun; Alexandra Macgregor; Jean-Philippe Boulenger; Marie-Christine Gely-Nargeot; Stéphane Raffard
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-05-26       Impact factor: 5.270

6.  The Value of Electronic Medical Record Implementation in Mental Health Care: A Case Study.

Authors:  Sanaz Riahi; Ilan Fischler; Melanie I Stuckey; Philip E Klassen; John Chen
Journal:  JMIR Med Inform       Date:  2017-01-05

7.  Experiences of antipsychotic use in patients with early psychosis: a two-year follow-up study.

Authors:  Rafal A H Yeisen; Jone Bjornestad; Inge Joa; Jan Olav Johannessen; Stein Opjordsmoen
Journal:  BMC Psychiatry       Date:  2017-08-22       Impact factor: 3.630

8.  The development and evaluation of a computerized decision aid for the treatment of psychotic disorders.

Authors:  Magda Tasma; Lukas O Roebroek; Edith J Liemburg; Henderikus Knegtering; Philippe A Delespaul; Albert Boonstra; Marte Swart; Stynke Castelein
Journal:  BMC Psychiatry       Date:  2018-06-01       Impact factor: 3.630

9.  An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia.

Authors:  Jinichi Hirano; Koichiro Watanabe; Takefumi Suzuki; Hiroyuki Uchida; Ryosuke Den; Taishiro Kishimoto; Takashi Nagasawa; Yusuke Tomita; Koichiro Hara; Hiromi Ochi; Yoshimi Kobayashi; Mutsuko Ishii; Akane Fujita; Yoshihiko Kanai; Megumi Goto; Hiromi Hayashi; Kanako Inamura; Fumiko Ooshima; Mariko Sumida; Tomoko Ozawa; Kayoko Sekigawa; Maki Nagaoka; Kae Yoshimura; Mika Konishi; Ataru Inagaki; Takuya Saito; Nobutaka Motohashi; Masaru Mimura; Yoshiro Okubo; Motoichiro Kato
Journal:  Neuropsychiatr Dis Treat       Date:  2013-10-11       Impact factor: 2.570

10.  Implementation of a clinical practice guideline for schizophrenia in a specialist mental health center: an observational study.

Authors:  Ilan Fischler; Sanaz Riahi; Melanie I Stuckey; Philip E Klassen
Journal:  BMC Health Serv Res       Date:  2016-08-11       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.